Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Net Income Margin for the year ending March 31, 2024: 6.00%

Yuki Gosei Kogyo Co., Ltd. Net Income Margin is 6.00% for the year ending March 31, 2024, a 38.56% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Yuki Gosei Kogyo Co., Ltd. Net Income Margin for the year ending March 31, 2023 was 4.33%, a 115.85% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Net Income Margin for the year ending March 31, 2022 was 2.01%, a -22.74% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Net Income Margin for the year ending March 31, 2021 was 2.60%, a 762.59% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Net Income Margin for the year ending March 31, 2020 was -0.39%, a -138.71% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Materials
Industries
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 2, 2025

Any question? Send us an email